Preparation and in vitro properties of folate receptor targeting docetaxel-loaded amphiphilic copolymer-modified liposomes

Yaoxue Xuebao

Volumn 47, Issue 9, 2012, Pages 1219-1226

  Li, Xiang ^a,b   Zhang, Jing ^a   Wang, Dong Kai ^b   Pan, Wei San ^b  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Composite design response surface methodology; Docetaxel; Encapsulation efficiency; Folate poly (PEG cyanoacrylate co cholesteryl cyanoacrylate)

Indexed keywords

DOCETAXEL; FOLATE RECEPTOR; LIPOSOME;

ARTICLE; DRUG SYNTHESIS; DYNAMIC LIGHT SCATTERING; ELECTROPHORETIC LIGHT SCATTERING; FOURIER TRANSFORM MASS SPECTROMETRY; IN VITRO STUDY; LIGHT SCATTERING; LIPOSOMAL DELIVERY; PROTON NUCLEAR MAGNETIC RESONANCE; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAFILTRATION; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; CHOLESTEROL ESTERS; CYANOACRYLATES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOLATE RECEPTORS, GPI-ANCHORED; LIPOSOMES; MOLECULAR WEIGHT; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; TAXOIDS;

EID: 84869203429     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Food and Drug Administration. Physicians'Desk Reference [M]. 51st ed. Rockville: Department of Public Health Services, 1997: 2204-2207.
2. Harrington KJ, Lewanski CR, Stewart JSW. Liposomes as vehicles for targeted therapy of cancer. Part I: Preclinical development [J]. Clin Oncol, 2000, 12: 2-15. (Pubitemid 30150769)
3. Xu H, Wang KQ, Huang WW, et al. Recent advances in the study of accelerated blood clearance phenomenon of PEGylated liposomes [J]. Acta Pharm Sin, 2010, 45: 677-683.
4. Zhao XB, Muthusamy N, Byrd JC, et al. Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes [J]. J Pharm Sci, 2007, 96: 2424-2435. (Pubitemid 47477897)
5. Gao WH, Liu ST, Fan CX, et al. Pharmacokinetics, tissue distribution and magnetic resonance's response characteristics of folic acid-O-carboxymethyl chitosan ultrasmall superpara-magnetic iron oxide nanoparticles in mice and rats [J]. Acta Pharm Sin, 2011, 46: 845-851.
6. Stella B, Arpicco S, Peracchia MT, et al. Design of folic acid-conjugated nanoparticles for drug targeting [J]. J Pharm Sci, 2000, 89: 1452-1464.
7. 10 against oxidative damage in human lens epithelial cells by novel ocular drug carriers [J]. Int J Pharm, 2011, 403: 219-229.
8. 10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect [J]. Int J Pharm, 2009, 372: 66-75.
9. Zhao F, Ma YL, Jin XL, et al. Preparation of ambroxol hydrochloride push-pull osmotic pump controlled-release tablets and its pharmacokinetics in dogs [J]. Acta Pharm Sin, 2011, 46: 1507-1514.
10. Yan WW, Qi XR, Wei L, et al. Cationic lipid and polyethylene glycol enhance liposomes-mediated cell transfection and increase the fluidity of liposomes membranes [J]. Acta Pharm Sin, 2003, 38: 698-701.
11. Muller RH, Lherm C, Herbort J, et al. In vitro model for the degradation of alkylcyanoacrylate nanoparticles [J]. Biomaterials, 1990, 11: 590-595. (Pubitemid 20367837)
12. Li YP, Pei YY, Zhou ZH, et al. PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers [J]. J Control Release, 2001, 71: 287-296. (Pubitemid 32276048)
13. Xu Y, Shi L, Deng YH. Effect of polyethylene glycol-lipid derivatives on the stability of grafted liposomes [J]. Acta Pharm Sin, 2011, 46: 1178-1186.
14. Bagnoli M, Canevari S, Figini M, et al. A step further in understanding the biology of the folate receptor in ovarian carcinoma [J]. Gynecol Oncol, 2003, 88: S140-S144.
15. Yan Y, Qi XR. Preparation and properties of folate receptor-targeted cationic liposomes [J]. Acta Pharm Sin, 2008, 43: 1134-1139.
16. Lu Y, Sega E, Leamon CP, et al. Folate receptor-targeted immunotherapy of cancer mechanism and therapeutic potential [J]. Adv Drug Deliv Rev, 2004, 56: 1161-1176. (Pubitemid 38496513)
17. Steinhauser I, Spänkuch B, Strebhardt K, et al. Trastuzumab-modified nanoparticles: optimization of preparation and uptake in cancer cells [J]. Biomaterials, 2006, 27: 4975-4983. (Pubitemid 43866920)
18. Shi B, Fang C, You MX, et al. Influence of PEG chain length on in vitro drug release and in vivo pharmacokinetics of hydroxycamptothecin (HCPT) loaded PEG-PHDCA niosomes [J]. Chin Pharm J, 2005, 40: 1643-1646. (Pubitemid 43219674)